<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <channel>
    <title>ZeroToIP Blog</title>
    <link>https://zerotoip.com/blog</link>
    <atom:link href="https://zerotoip.com/blog/feed.xml" rel="self" type="application/rss+xml" />
    <description>IP strategy for deep tech founders, written with Castle Fund.</description>
    <language>en</language>
    <lastBuildDate>Mon, 28 Sep 2026 00:00:00 GMT</lastBuildDate>
    <item>
      <title>How IP Strategy Differs Across Sectors: Biotech, Energy &amp; Space</title>
      <link>https://zerotoip.com/blog/ip-strategy-across-sectors</link>
      <guid isPermaLink="true">https://zerotoip.com/blog/ip-strategy-across-sectors</guid>
      <pubDate>Mon, 28 Sep 2026 00:00:00 GMT</pubDate>
      <description>The same patent-versus-secret framework produces three different portfolios in biotech, energy and space. The variable nobody prices is which statute your adversary sits behind.</description>
      <category>IP Strategy</category>
      <dc:creator>Kunal Chandiramani &amp; Daniel Gould</dc:creator>
    </item>
    <item>
      <title>When Not to Patent: Trade Secrets, Stealth Launches &amp; the Public Record</title>
      <link>https://zerotoip.com/blog/when-not-to-patent</link>
      <guid isPermaLink="true">https://zerotoip.com/blog/when-not-to-patent</guid>
      <pubDate>Mon, 15 Jun 2026 00:00:00 GMT</pubDate>
      <description>The patent system demands a trade. Before you make it, make sure you're getting the better end of the deal.</description>
      <category>IP Strategy</category>
      <dc:creator>Kunal Chandiramani &amp; Daniel Gould</dc:creator>
    </item>
    <item>
      <title>Why Your IP Portfolio Could Be Your Most Undervalued Asset</title>
      <link>https://zerotoip.com/blog/ip-portfolio-undervalued-asset</link>
      <guid isPermaLink="true">https://zerotoip.com/blog/ip-portfolio-undervalued-asset</guid>
      <pubDate>Fri, 20 Mar 2026 00:00:00 GMT</pubDate>
      <description>Most founders treat patents as a legal checkbox and don't even mention trade secrets. The investors writing your next term sheet probably see them differently.</description>
      <category>IP Strategy</category>
      <dc:creator>Kunal Chandiramani &amp; Daniel Gould</dc:creator>
    </item>
  </channel>
</rss>
